Related references
Note: Only part of the references are listed.Beneficial Effect of a CNTF Tetrapeptide on Adult Hippocampal Neurogenesis, Neuronal Plasticity, and Spatial Memory in Mice
Julie Blanchard et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil
X. A. Alvarez et al.
Current Alzheimer Research (2011)
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
X. A. Alvarez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Beneficial Effects of a Neurotrophic Peptidergic Mixture Persist for a Prolonged Period Following Treatment Interruption in a Transgenic Model of Alzheimer's Disease
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide
Muhammad Omar Chohan et al.
NEUROBIOLOGY OF AGING (2011)
Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
L. Crews et al.
CELL DEATH & DISEASE (2011)
Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice
Julie Blanchard et al.
ACTA NEUROPATHOLOGICA (2010)
Spotlight on Cerebrolysin in Dementia
Greg L. Plosker et al.
CNS DRUGS (2010)
Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice
Bin Li et al.
FEBS LETTERS (2010)
Cholinergic Involvement in Alzheimer's Disease. A Link with NGF Maturation and Degradation
A. Claudio Cuello et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Increased BMP6 Levels in the Brains of Alzheimer's Disease Patients and APP Transgenic Mice Are Accompanied by Impaired Neurogenesis
Leslie Crews et al.
JOURNAL OF NEUROSCIENCE (2010)
Cerebrolysin Enhances Neurogenesis in the Ischemic Brain and Improves Functional Outcome After Stroke
Chunling Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Cell Death and Learning Impairment in Mice Caused by in Vitro Modified Pro-NGF Can Be Related to Its Increased Oxidative Modifications in Alzheimer Disease
Anton Kichev et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Cerebrolysin A Review of its Use in Dementia
Greg L. Plosker et al.
DRUGS & AGING (2009)
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
Alan H. Nagahara et al.
NATURE MEDICINE (2009)
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Mathew Blurton-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndrome
Edith Doppler et al.
ACTA NEUROPATHOLOGICA (2008)
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice
Brian Spencer et al.
BMC NEUROSCIENCE (2008)
Neurotrophic factors in Alzheimer's disease:: role of axonal transport
K. Schindowski et al.
GENES BRAIN AND BEHAVIOR (2008)
Analysis of cerebrospinal fluid of Alzheimer patients
Josef Marksteiner et al.
PHARMACOLOGY (2008)
Transgenic animal models of neurodegenerative diseases and their application to treatment development
Edward Rockenstein et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons
Kuel-Cheng Lim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis
Honghui Chen et al.
NEUROBIOLOGY OF AGING (2007)
The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease
A. Claudio Cuello et al.
NEUROCHEMICAL RESEARCH (2007)
Effects of Cerebrolysin™ on neurogenesis in an APP transgenic model of Alzheimer's disease
Edward Rockenstein et al.
ACTA NEUROPATHOLOGICA (2007)
Nerve growth factor gene therapy in Alzheimer disease
Mark H. Tuszynski
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Small molecule neurotrophin receptor ligands: Novel strategies for targeting Alzheimer's disease mechanisms
Frank M. Longo et al.
CURRENT ALZHEIMER RESEARCH (2007)
Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis
Petar Podlesniy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease
Simona Capsoni et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Cerebrolysin decreases amyloid-β production by regulating amyloid protein precursor maturation in a Transgenic model of Alzheimer's disease
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease
XA Alvarez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease
SY Peng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Cutting back on pro-protein convertases:: the latest approaches to pharmacological inhibition
M Fugère et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound Cerebrolysin™
E Rockenstein et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR
CE Pedraza et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury
AW Harrington et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
SY Peng et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Aβ1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
E Masliah et al.
NEUROLOGY (2003)
The neuroprotective effects of Cerebrolysin (TM) in a transgenic model of Alzheimer's disease are associated with improved behavioral performance
E Rockenstein et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Early formation of mature amyloid-β protein deposits in a mutant APP transgenic model depends on levels of Aβ1-42
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
M Fahnestock et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)
Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor
Y Tomidokoro et al.
NEUROSCIENCE LETTERS (2000)
Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy
E Ruther et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
